Related Experiment Videos
Study of circulating immune complex size in systemic lupus erythematosus
Clinical and Experimental Immunology
|March 1, 1981
Summary
Molecular size of immune complexes in systemic lupus erythematosus (SLE) patients varies by clinical manifestation. Large complexes correlate with membranous glomerulonephritis, small with cerebritis, and both with diffuse proliferative glomerulonephritis or no renal involvement.
Area of Science:
- Immunology
- Nephrology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune complex deposition.
- The size of circulating immune complexes (CICs) may correlate with specific organ involvement and disease activity in SLE.
Purpose of the Study:
- To investigate the relationship between the molecular size of CICs and clinical manifestations in SLE patients.
- To determine if CIC size can predict renal involvement or disease activity.
Main Methods:
- Sera from SLE patients were fractionated using sucrose-gradient ultracentrifugation.
- The C1q solid-phase assay was employed to detect and quantify CICs.
- CICs were categorized as large (>19S) or small (7S).
Main Results:
- Patients with membranous glomerulonephritis had exclusively large CICs (>19S).
- Patients with cerebritis had predominantly small CICs (7S).
- SLE patients with diffuse proliferative glomerulonephritis or no renal involvement exhibited both large and small CICs. CIC levels were higher in active disease states, particularly in patients without renal involvement.
Conclusions:
- The molecular size of CICs is associated with distinct clinical phenotypes in SLE.
- CIC size may serve as a biomarker for predicting specific organ damage and disease activity in SLE patients.